Next Article in Journal
The Influence of Nucleoside Reverse Transcriptase Inhibitors on Mitochondrial Activity, Lipid Content, and Fatty-Acid-Binding Protein Levels in Microglial HMC3 Cells
Next Article in Special Issue
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study)
Previous Article in Journal
Photodynamic Therapy Directed to Melanoma Skin Cancer by Thermosensitive Hydrogel Containing Chlorophyll A
Previous Article in Special Issue
Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(12), 1660; https://doi.org/10.3390/ph16121660
Action Date Notes Link
article xml file uploaded 29 November 2023 08:56 CET Original file -
article xml uploaded. 29 November 2023 08:56 CET Update https://www.mdpi.com/1424-8247/16/12/1660/xml
article pdf uploaded. 29 November 2023 08:56 CET Version of Record https://www.mdpi.com/1424-8247/16/12/1660/pdf
article supplementary file uploaded. 29 November 2023 08:56 CET - https://www.mdpi.com/1424-8247/16/12/1660#supplementary
article html file updated 29 November 2023 08:58 CET Original file https://www.mdpi.com/1424-8247/16/12/1660/html
Back to TopTop